Siemens, Merck seek drug production breakthrough
6 Articles
6 Articles
Through a memorandum of understanding, Merck KGaA and Siemens deepened their collaboration in life sciences with the aim of accelerating drug development. The alliance seeks to integrate Artificial Intelligence (IA), automation and advanced data management to connect more fluidly all stages of a drug’s life cycle, from discovery to production. Given that the cost of drug development and manufacture is doubled in a very short time, companies want…
Merck and Siemens have deepened their strategic partnership with a new memorandum of understanding to accelerate digital transformation in the life sciences industry. The memorandum of understanding (MoU) focuses on the development of integrated software solutions based on automation...
Merck and Siemens expand partnership to advance AI in drug discovery
Merck and Siemens have signed a new Memorandum of Understanding (MoU), extending their strategic partnership to accelerate digital transformation in the life science industry by connecting digital and physical products. The agreement focuses on delivering integrated software solutions, systems and consumables that harness automation, data and AI to connect drug discovery, development, and manufacturing. This agreement marks the first joint use o…
Siemens, Merck seek drug production breakthrough
Science and technology company Merck Group and Siemens went deeper on a longstanding partnership with plans to turn an eye to developing software, systems and consumable items to aid in drug production. A memorandum of understanding involves commitments to employ automation, data and AI to advance the discovery of new drugs, and then develop and produce them. Siemens and Merck hope their digital-first approach will close gaps in the processes be…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium